Invitrogen
This article was originally published in The Gray Sheet
Executive Summary
Research partnership with the Novartis Institute for Functional Genomics is announced Dec. 17. The agreement allows Novartis access to Invitrogen's cloning and expression kits in exchange for commercial rights to any genes discovered by NIFG using the technology (1see related story, p. 19)